Neoadjuvant chemotherapy vs, radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): Preliminary results of randomized phase II trial

被引：6
|
作者：
Pereira, JR
Martins, SJ
Ikari, FK
Nikaedo, SM
Gampel, O
机构：
[1] Arnaldo Vieira Carvalho Canc Inst, Sao Paulo, Brazil
[2] Paulista Lung Canc Treatment Grp, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81452-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1032
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [1] Radiotherapy of superior vena cava syndrome (SVCS) caused by non-small cell lung cancer (NSCLC)
    Vodvarka, P
    LUNG CANCER: CURRENT TOPICS, 2001, : 279 - 284
  • [2] SUPERIOR VENA-CAVA SYNDROME DUE TO NON SMALL-CELL LUNG-CANCER - RESOLUTION WITH CHEMOTHERAPY ALONE
    CITRON, ML
    FOSSIECK, BE
    KRASNOW, SH
    JOHNSTONEARLY, A
    COHEN, MH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (01): : 71 - 72
  • [3] Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)
    Dimakakos, E.
    Grammoustianou, M.
    Sarropoulou, F.
    Kouvela, M.
    Gkiozos, I.
    Kotteas, E.
    Gerotziafas, G.
    Mavroudis, D.
    Syrigos, K. N.
    THROMBOSIS RESEARCH, 2022, 213 : S29 - S29
  • [4] Chemotherapy for superior vena cava syndrome due to non-small cell lung cancer: experience of the Paulistan Lung Cancer Treatment Group
    Pereira, JR
    Martins, SJ
    Stuart, SR
    Maia, MAC
    Minamoto, H
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 633 - 637
  • [5] PHASE-II RANDOMIZED TRIAL OF RADIOTHERAPY ALONE VS THE SEQUENTIAL USE OF CHEMOTHERAPY AND RADIOTHERAPY IN STAGE-III NON-SMALL CELL LUNG-CANCER - PHASE-II TRIAL OF CHEMOTHERAPY ALONE IN STAGE-IV NON-SMALL CELL LUNG-CANCER
    WILS, JA
    UTAMA, I
    NAUS, A
    VERSCHUEREN, TA
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (07): : 911 - 914
  • [6] Superior Vena Cava Syndrome Developing in Non-small Cell Lung Cancer
    Rajagopal, Anita
    Simala, Jon
    CHEST, 2014, 145 (03)
  • [7] NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    WATKIN, SW
    ERRINGTON, RD
    GREEN, JA
    WARENIUS, HM
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 231 - 231
  • [8] Randomized, phase II trial of NGR-hTNF and chemotherapy in chemotherapy-naive patients with non-small cell lung cancer (NSCLC): Preliminary results.
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Bulotta, A.
    Vitali, M.
    Barletta, G.
    Bergamaschi, L.
    Platania, M.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial
    Besse, B.
    Adam, J.
    Cozic, N.
    Chaput-Gras, N.
    Planchard, D.
    Mezquita, L.
    Remon Masip, J.
    Lavaud, P.
    Naltet, C.
    Gazzah, A.
    de Montpreville, V. Thomas
    Ghigna, M. -R.
    Mussot, S.
    Fadel, E.
    Mabille, L.
    Duchemann, B.
    Barlesi, F.
    Soria, J-C.
    Caramella, C.
    Mercier, O.
    ANNALS OF ONCOLOGY, 2020, 31 : S794 - S795
  • [10] Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) - Preliminary Results
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Citterio, G.
    Platania, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S596 - S596
12345